Literature DB >> 26024573

Ginsenosides and their metabolites: a review of their pharmacological activities in the skin.

Tae-Gyu Lim1, Charles C Lee, Zigang Dong, Ki Won Lee.   

Abstract

Ginsenosides are representative pharmaceutical compounds found in various forms in Panax ginseng, a traditional medicinal plant. They are converted to their metabolites Rg2, Rg3, compound K, and others by human intestinal microflora following ingestion. Numerous studies have demonstrated beneficial effects of ginsenosides against aberrant molecular processes responsible for cancer, metabolic diseases and neurodegenerative diseases. Recently, antiaging effects of ginsenosides in human skin have been reported from clinical trial and in vitro model data. Ginsenosides have hence been proposed as promising natural cosmeceutical agents. In this review, we will critically review the known biological effects of several ginsenosides (Rb1, Rg3, Rd and compound K), such as anti-inflammatory and anticancer activities, which arise from the modulation of diverse molecular pathways. The application potential of ginsenosides as cosmeceutical ingredients will also be reviewed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26024573     DOI: 10.1007/s00403-015-1569-8

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

1.  Examination of Combined Treatment of Ginsenoside Rg3 and 5-Fluorouracil in Lung Adenocarcinoma Cells.

Authors:  Kuizhong Shan; Yujiang Deng; Zhiquan Du; Peiyu Yue; Sufang Yang
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

2.  Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM.

Authors:  Fenglin Jiang; Chen Zhou; Yan Li; Haidong Deng; Ting Gong; Jingjing Chen; Tianjiao Chen; Jinling Yang; Ping Zhu
Journal:  Acta Pharm Sin B       Date:  2022-04-27       Impact factor: 14.903

3.  In vitro antioxidative and anti-inflammatory effects of the compound K-rich fraction BIOGF1K, prepared from Panax ginseng.

Authors:  Muhammad Jahangir Hossen; Yong Deog Hong; Kwang-Soo Baek; Sulgi Yoo; Yo Han Hong; Ji Hye Kim; Jeong-Oog Lee; Donghyun Kim; Junseong Park; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2016-01-06       Impact factor: 6.060

4.  MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells.

Authors:  Xiao-Dong Wu; Ting Guo; Li Liu; Chao Wang; Kun Zhang; Han-Qiang Liu; Feng Wang; Wen-Dong Bai; Meng-Yao Zhang
Journal:  Oncotarget       Date:  2017-07-22

5.  Chemical Distance Measurement and System Pharmacology Approach Uncover the Novel Protective Effects of Biotransformed Ginsenoside C-Mc against UVB-Irradiated Photoaging.

Authors:  Xiao-Yi Liu; Hui Li; Eunson Hwang; Bom Park; Yong-Kun Xiao; Senmiao Liu; Jiansong Fang; Yeon-Ju Kim; Tae-Hoo Yi; Chuipu Cai
Journal:  Oxid Med Cell Longev       Date:  2022-02-09       Impact factor: 6.543

6.  Ginsenoside Rg3 Decreases Fibrotic and Invasive Nature of Endometriosis by Modulating miRNA-27b: In Vitro and In Vivo Studies.

Authors:  Min Kyoung Kim; Seung Kyun Lee; Ji Hyun Park; Jae Hoon Lee; Bo Hyon Yun; Joo Hyun Park; Seok Kyo Seo; SiHyun Cho; Young Sik Choi
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.